Ultime notizie per Better Therapeutics (OTC:BTTX) Azioni

Better Therapeutics

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

BETTER THERAPEUTICS INC by Better Therapeutics, Inc.

Better Therapeutics Inc

Scotiabank analyst Eric Winmill maintains Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) with a Sector Outperform and lowers the price target from $2.5 to $2.25.

News

Price Target

Analyst Ratings

GROY

Scotiabank Maintains Sector Outperform on Gold Royalty, Lowers Price Target to $2.25

Scotiabank analyst Ben Isaacson maintains Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) with a Sector Outperform and lowers the price target from $60 to $50.

Scotiabank Maintains Sector Outperform on Sociedad Quimica Y Minera, Lowers Price Target to $50

Formula 1 is expanding with an 11th team joining the global motorsport for the 2026 season, naming General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) <a href="https://www.benzinga.com/24/11/42135392/general-motors-gears-up-for-potential-f1-entry-in-2026-report">with Andretti Global.</a>
While the new team is still over a year away from starting, it will add an increased American presence to the sport and more competition for recent and four-time consecutive champion <a href="https://www.benzinga.com/general/education/21/12/24561188/max-verstappen-claims-his-first-f1-world-championship-5-things-you-might-not-know-about-the-for">Max Verstappen.</a>
What Happened: Formula 1, which is a unit of publicly traded Liberty Formula One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>), announced it reached an agreement with General Motors for a new team, branded as Cadillac, which will enter beginning in 2026, following up a previous rejection of a GM-linked team <a href="https://www.benzinga.com/general/entertainment/24/01/36875148/formula-one-rejects-andretti-general-motors-team-bid-what-this-could-mean-for-us-growth-esp">earlier this year.</a>
General Motors will also become an engine supplier for the league at a later date, the league <a href="https://www.formula1.com/en/latest/article/statement-on-general-motors-application-to-join-fia-formula-one-world.69uoRF1uwHwXkr4efkpnhc">announced</a>. The GM team will use Ferrari engines until the GM engines are officially approved for the sport.
"With Formula 1's continued growth plans in the U.S., we have always believed that welcoming an impressive U.S. brand like GM/Cadillac to the grid and GM as a future power unit supplier could bring additional value and interest to the sport," Liberty Media CEO Greg Maffei said.
General Motors President Mark Reuss called Formula 1 the "pinnacle of motorsports" and said the announcement of becoming the 11th team is an honor for the automotive company.
"We're committed to competing with passion and integrity to elevate the sport for race fans around the world," Reuss said. "This is a global stage for us to demonstrate GM's engineering expertise and technology leadership at an entirely new level."
The approval of the team comes after the U.S. Justice Department launched an investigation into why Liberty Media, who owns the commercial rights to Formula 1, would not approve the American team bid started by Michael Andretti.
The new team, called Cadillac F1, will be run by Andretti Global majority owners Dan Towriss and Mark Walter after Andretti stepped aside from the group in September. Former Formula 1 champion and racing legend Mario Andretti will have an ambassador role with Cadillac F1 while his son Michael will have no official position.
Read Also: <a href="https://www.benzinga.com/general/entertainment/23/12/36222143/netflix-lands-more-live-sports-how-success-of-docuseries-helped-pave-the-way">Netflix Lands More Live Sports: How Success Of Docuseries Helped Pave The Way</a>
Why It's Important: The announcement comes after Formula 1's Las Vegas Grand Prix, one of three U.S. races in 2024, was recently held and saw Max Verstappen <a href="https://www.espn.com/f1/story/_/id/42520866/max-verstappen-wins-fourth-f1-world-title-las-vegas-red-bull">win </a>his fourth consecutive Formula 1 World Championship.
While Verstappen finished fifth in the race, he secured enough points to guarantee that no one could match his points total with two races left in the season. This marks the fourth consecutive title by Verstappen with his first title in 2021 a close one with<a href="https://www.benzinga.com/general/sports/24/02/36897433/f1-legend-lewis-hamilton-set-to-join-ferrari-likely-to-replace-sainz-in-major-team-shake-up"> racing legend Lewis Hamilton.</a>
Verstappen has been dominant in the sport in recent years winning the title with races still left in season three of the four years. Verstappen won seven of the first 10 races this season before falling out of form but later did enough to win enough points to secure the title.
The new GM team marks the second American-owned team. Gene Haas owns a team but chooses to have international drivers. Michael Andretti's original vision was to have an American-owned team and also feature American drivers, something that fans of the sport will be closely watching.
Team expansion has been infrequent with four teams added in 2010 to push the total to 13 teams and 26 cars. Of the four teams added, one never raced and the other three were out of the league by 2017, as <a href="https://apnews.com/article/f1-grid-expansion-11th-team-andretti-9ffab2a3b1c71d59bd838b1c154b690f?taid=6744c0a5988d9800014d4a8b&amp;utm_campaign=TrueAnthem&amp;utm_medium=AP&amp;utm_source=Twitter">reported </a>by the Associated Press. &nbsp;
The existing 10 team owners have been against expansion due to the dilution of prize money, but have no formal say in the approval process.
Adding another American team could benefit ESPN, which is a unit of Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>). ESPN secured the renewal of the U.S. rights in 2022, paying an estimated $75 million to $90 million annually for the rights for three additional years.
ESPN fought off several other parties interested in the rights, as viewership for the sport has surged in recent years.
Along with recent growth in viewership in the U.S. Formula One teams have also experienced increased interest in ownership stakes from investors, including several notable American football players.
The Alpine racing team received&nbsp;<a href="https://www.formula1.com/en/latest/article.patrick-mahomes-travis-kelce-anthony-joshua-and-rory-mcilroy-among-host-of.3J4ua82zLZnEDJuM5Cegpe.html" target="_blank" rel="noreferrer noopener">investments&nbsp;</a>in 2023 from Kansas City Chiefs players&nbsp;Patrick Mahomes&nbsp;and&nbsp;Travis Kelce, professional golfer&nbsp;Rory McIlroy&nbsp;and actor&nbsp;Ryan Reynolds.
FWONA Price Action: Liberty Formula One shares were up 4.25% to $80.74 on Monday, hitting an intraday high of $80.88, which is a new 52-week high. The stock is up 41% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/41099414/ryan-reynolds-has-built-multiple-billion-dollar-brands-will-marketing-company-named-after-d">Ryan Reynolds&#8217; Billion-Dollar Streak: Will His Viral Marketing Firm Go Public Next?</a></li>
</ul>
Photo: Jay Hirano Photography via Shutterstock

Sports

Movers

Trading Ideas

FWONA

FWONK

Formula 1 Stock Hits 52-Week High, Announces 11th Team With General Motors/Andretti Global After Max Verstappen's Fourth Straight Title

SNBR

Sleep Number Issues Response To Public Letter To Shareholders From Stadium Capital Management; Reiterates That Its Highest Priority Is Identifying And Recruiting Optimal CEO Candidate

Scotiabank analyst Meny Grauman maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Sector Outperform and raises the price target from C$112 to C$147.

TSX:BMO

Scotiabank Maintains Sector Outperform on Bank of Montreal, Raises Price Target to C$147

The Company expects the Restated Financial Statements to reflect the following approximate impacts: as of December 31, 2023, (i) an increase in assets of $190 million, (ii) an increase in accrued expenses and other liabilities of $783 million, and (iii) a decrease in retained earnings of $593 million.&nbsp;
For the years ended December 31, 2023 and 2022, pre-tax income would be reduced by approximately $190 million to $3,636 million and $77 million to $5,641 million, respectively. For the third quarter of 2024, pre-tax income would decrease by approximately $6 million to $1,282 million while pre-tax income for the nine months ended September 30, 2024 would increase by approximately $700 million to $4,462 million (as compared to the pre-tax income reported in the financial information with respect to the quarter ended September 30, 2024 in the exhibits furnished with the Company's Current Report on Form 8-K filed with the SEC on October 16, 2024).

Discover Financial Services Gets NYSE Notice Regarding Filing Of Form 10-Q; Plans To Restate Certain Prior Period Financial Statements

Scotiabank analyst Meny Grauman maintains Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) with a Sector Outperform and raises the price target from C$85 to C$108.

TSX:CM

Scotiabank Maintains Sector Outperform on Canadian Imperial Bank, Raises Price Target to C$108

Guidance

LexinFintech Says Cautious About Short-term Economic Outlook And Anticipate Recently Released Government Stimulus Measures Targeting Economic Recovery To Gradually Take Effect

Dividends

LexinFintech Board Approves Amended Dividend Payout Policy, Increasing Payout Ratio To 25% Of Net Profit Starting In 2025

Scotiabank analyst Meny Grauman maintains Royal Bank of Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RY#TSX">RY</a>) with a Sector Outperform and raises the price target from C$167 to C$197.

TSX:RY

Scotiabank Maintains Sector Outperform on Royal Bank of Canada, Raises Price Target to C$197

LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) reported quarterly earnings of $0.28 per share. The company reported $521.85 in sales this quarter. This is a 100.00 percent decrease over sales of $480.94 million the same period last year.

Earnings

LexinFintech Holdings Q3 2024 Adj EPS $0.28, Sales $521.85M

Scotiabank analyst Meny Grauman maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Sector Outperform and raises the price target from C$86 to C$98.

TSX:TD

Scotiabank Maintains Sector Outperform on Toronto-Dominion Bank, Raises Price Target to C$98

Flint, Michigan&#8217;s <a href="https://lightnupcannabis.com/">Light'N Up Cannabis Company</a> is helping local families in need celebrate Thanksgiving with its annual give away of 1,000 turkeys this past Saturday.
"Once you get something like this started, it takes on a life of its own and is more fun and more rewarding each year," said Light'N Up founder Kyle Cohee.
"We've been through some tough times here in Flint, and people deserve every single break we can provide," he said. "Giving them the central part of a Thanksgiving meal is our honor and our way of thanking the people of Flint for supporting our store."
The veteran-owned business set aside 300 of the 1,308 turkeys for Vet Life, a local nonprofit serving veterans. Another eight turkeys went to the North End Soup Kitchen and area churches to help others in need.
Country music artist and veteran advocate Stephen Cochran joined the event, adding to the day's community spirit.
See Also: <a href="https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</a>
<h3 class="wp-block-heading">Cannabis-Infused Thanksgiving In Arizona</h3>
Meanwhile, in Arizona, Mint Café, the state's first and only canna-kitchen, is putting a unique twist on Thanksgiving dinner. 
According to WDRB, the dispensary is offering a selection of cannabis-infused dishes, including THC-infused gravy, cranberry sauce, garlic herb butter and cornbread. For dessert, customers can choose between pumpkin and pecan pies, also infused with THC.
These special menu items will be available to adults 21 and older, providing an alternative way to enjoy a Thanksgiving feast.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/41843473/how-to-microdose-cannabis-for-a-stress-free-holiday-season-tips-for-newcomers">How To Microdose Cannabis For Stress-Free Holiday Season: Tips For Newcomers</a></li>
</ul>
Cover image made with AI.

Cannabis

Restaurants

1,000 Free Turkeys Donated By Michigan Dispensary, Cannabis-Infused Thanksgiving Feasts In Arizona

Citigroup analyst Michael Griffin maintains CBRE Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) with a Buy and raises the price target from $130 to $160.

CBRE

Citigroup Maintains Buy on CBRE Group, Raises Price Target to $160

Nuveen California Dividend Advantage Municipal Fund 2

Trading Halt: Halted at 5:53:28 p.m. ET - Trading Halt: Halt News Pending

The two lucky turkeys this year, Peach and Blossom from Minnesota, escaped the hatchet when President Joe Biden pardoned them in the annual pre-Thanksgiving tradition at the White House Monday.
&#8220;This event marks the official start of the holiday season here in Washington,&#8221; Biden <a href="https://abcnews.go.com/Politics/peach-blossom-continue-white-house-turkey-tradition/story?id=116182776">said</a> to a crowd of 2,500 gathered on the South Lawn. &#8220;It&#8217;s also my last time to speak here as your president during this season and give thanks and gratitude. So let me say to you, it&#8217;s been the honor of my life. I&#8217;m forever grateful.&#8221;
Read Also: <a href="https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</a>
<h1 class="wp-block-heading">Don't Forget Those Others You Promised To Pardon</h1>
It's been over two years since&nbsp;<a href="https://www.benzinga.com/topic/joe-biden" target="_blank" rel="noreferrer noopener">Biden</a>&#8216;s announcement to pardon all prior federal offenses&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/10/29175510/breaking-biden-announces-pardons-for-all-federal-marijuana-possession-convictions" target="_blank" rel="noreferrer noopener">of simple marijuana possession</a>. It must be pointed out that not one single person among the approximately 3,000 people incarcerated for federal cannabis offenses has been released.
To remedy that situation, the&nbsp;<a href="https://www.benzinga.com/topic/last-prisoner-project" target="_blank" rel="noreferrer noopener">Last Prisoner Project</a>&nbsp;(LPP) has a great idea for the soon-to-be-retired president: release those prisoners immediately. 
In its People Not Poultry project, the LPP is calling on Biden to free the thousands of non-violent cannabis prisoners still incarcerated for offenses that are now legal in more than half the country. Last week, the LPP joined a chorus of advocates and over 60 Congress members in&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/11/42122853/67-lawmakers-urge-biden-to-grant-clemency-to-people-still-in-jail-for-cannabis-offenses">sending a letter</a>&nbsp;to Biden seeking clemency so families can be reunited for the holidays.
In a press conference on the capitol steps, LPP Director of Strategic Initiatives Jason Ortiz, said, "Sadly, as of today, President Biden has given freedom to more turkeys than he has to people [incarcerated for cannabis]. This is a gross injustice and an injustice that President Biden can correct with a stroke of a&nbsp;pen."&nbsp;
<h1 class="wp-block-heading">Think Of Your Legacy, President Biden</h1>
&#8220;But time is running out for President Biden to use this power effectively," LPP wrote in a press statement shared with Benzinga in October. &#8220;As President Biden approaches the final months of his presidency, he has the unique opportunity to correct the injustices of the War on Drugs that he once helped champion. By commuting the sentences of those still incarcerated for cannabis, he can take a bold stand for justice, equity and healing.&#8221;
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales">Green Wednesday&#8217;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales</a></li>
</ul>
Courtesy photo of National Turkey Federation with NTF chairman John Zimmerman and his son with President Joe Biden

Government

Legal

Joe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?

Tigress Financial analyst Ivan Feinseth maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and raises the price target from $96 to $103.

UBER

Tigress Financial Maintains Buy on Uber Technologies, Raises Price Target to $103

Legendary investor Warren Buffett has announced new charitable donations and updates to how his fortune will be spent after he is gone, news that comes months after he turned<a href="https://www.benzinga.com/general/education/24/08/40652464/warren-buffett-celebrates-94th-birthday-with-1-trillion-market-cap-milestone-a-look-back-at-hig"> 94 years old.</a>
What Happened: Buffett announced Monday that he is converting 1,600 Berkshire Hathaway Class A (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares into 2,400,000 Berkshire Hathaway Class B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares to make new donations as part of his<a href="https://www.benzinga.com/startups/24/11/41866296/with-warren-buffett-donating-99-of-his-fortune-whats-left-for-his-three-children-well-its-complicated"> continued philanthropic efforts.</a>
Buffett is donating 1,500,000 Class B shares to The Susan Thompson Buffett Foundation and 300,000 shares to each of The Sherwood Foundation, The Howard G. Buffett Foundation and NoVo Foundation.
After the latest donation, Buffett will own 206,363 Class A shares, down 56.6% since his 2006 Giving Pledge.
Buffett recalled his belief and his late wife Susie's belief to support their children and philanthropic efforts in a new shareholder <a href="https://www.berkshirehathaway.com/news/nov2524.pdf">letter</a>.
"These bequests reflected our belief that hugely wealth parents should leave their children enough so they can do anything but not enough that they can do nothing," Buffett said. "Susie and I had long encouraged our children in small philanthropic activities and had been pleased with their enthusiasm, diligence and results."
Buffett said he is lucky to have lived as long as he has, while also recognizing his current age and the age of his children who are 71, 69 and 66.
"Father time always wins. But he can be fickle — indeed unfair and even cruel — sometimes ending life at birth or soon thereafter while, at other times, waiting a century or so before paying a visit."
Buffett said he never wished to create a family dynasty and trusts his children to pursue his wishes to continue philanthropic donations, along with successor trustees younger than his children.
"As such, three potential successor trustees have been designated. Each is well known to my children and makes sense to all of us."
Read Also: <a href="https://www.benzinga.com/general/education/24/10/41418702/warren-buffetts-words-of-wisdom-benzinga-readers-pick-their-favorite-oracle-of-omaha-quote">Warren Buffett&#8217;s Words Of Wisdom: Benzinga Readers Pick Their Favorite Oracle Of Omaha Quote</a>
Why It's Important: Buffett said friends question his strategies for donating his wealth and the instructions left for his children.
"I have one further suggestion for all parents, whether they are of modest or staggering wealth. When your children are mature, have them read your will before they sign it," Buffett said.
Buffett said it's important that children understand the logic of decisions and any responsibilities that they will take on after your death.
"You don't want your children asking "Why?" in respect to testamentary decisions when you are no longer able to respond."
Buffett recalls his life's success and early confidence that he could become rich.
"By not stepping on any banana peels, I now remain in circulation at 94 with huge sums in savings — call these units of deferred consumption — that can be passed along to others who were given a very short straw at birth."
The legendary investor said he lived his life the way he wanted by taking good care of his family and passing on wealth to others.
"With this philosophy, I have lived the way I wanted to live since my late 20s, and I have now watched my children grow into good and productive citizens."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/23/05/32270873/warren-buffett-shares-advice-on-succeeding-at-life-heres-how-your-obituary-could-be-involved">Warren Buffett Shares Advice On Succeeding At Life: Here&#8217;s How Your Obituary Could Be Involved</a></li>
</ul>
Photo: Shutterstock

Warren Buffett Announces New Charitable Gifts, Updates Plans For $150B Fortune: Billionaire Wants To Help Others 'Given A Very Short Straw At Birth'

The company said new data supports the value of the Oncotype DX Breast Recurrence Score test in guiding treatment decisions, improving outcomes, and managing costs for breast cancer patients globally.

EXAS

Exact Sciences To Present 10 Abstracts Demonstrating Breadth Of Its Precision Oncology Portfolio At SABCS

Minnesota&#8217;s journey toward a recreational cannabis market hit a roadblock Monday when a local judge delayed the state's first lottery for cannabis business licenses.
The decision follows lawsuits filed by applicants who claim they were unfairly excluded from the process, <a href="https://www.startribune.com/minnesotas-first-lottery-for-cannabis-business-licenses-delayed-amid-litigation/601186596">reported</a> The Minnesota Star Tribune. 
Judge Stephen Smith ordered the state's Office of Cannabis Management (OCM) to postpone the Tuesday lottery for social equity applicants. The delay aims to provide the Court of Appeals time to address legal challenges raised by the rejected applicants.
The lottery is set to grant 282 social equity applicants pre-approval for cannabis business licenses. This move may impact the timeline for launching Minnesota's retail cannabis market.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/08/40149945/minnesota-cannabis-update-as-industry-prepares-to-launch-retail-sales"> Minnesota Cannabis Update As Industry Prepares To Launch Retail Sales</a>
<h3 class="wp-block-heading">Rejections Spark Lawsuits</h3>
Out of <a href="https://www.benzinga.com/markets/cannabis/24/08/40518244/minnesota-prepares-for-historic-social-equity-lottery-with-1-817-applications-for-280-cannabis-l">1,817 applicants</a>, 1,169 were denied entry into the lottery. The OCM cited failures to meet qualifying standards or submit proper documentation as reasons for rejection. However, rejected applicants argue the process lacked transparency and clarity.
Attorney Courtney Ernston, representing one of the plaintiffs, criticized the vague nature of rejection notices. "Simply saying the word ‘fail' is not a reason," Ernston said, adding that her client received no detailed explanation for her exclusion. Applicants and their legal representatives contend that the lack of transparency undermines their ability to contest or correct the rejections.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.
<h3 class="wp-block-heading">Implications For Minnesota's Cannabis Market</h3>
The delayed lottery raises concerns about potential setbacks in establishing <a href="https://www.benzinga.com/topic/minnesota-cannabis">Minnesota's</a> cannabis market.
The program&#8217;s social equity focus aims to prioritize individuals disproportionately affected by past cannabis prohibition, Gov. Tim Walz <a href="https://www.benzinga.com/markets/cannabis/24/02/37164553/gov-waltz-stresses-importance-of-social-equity-in-minnesotas-cannabis-market-marginalized-commun">pointed out</a> in an interview in February.
&#8220;Philosophically our goal is to make sure the equity piece was a big part of this. We certainly want to stay within the parameters of the law of who we can give help to. But I think the idea was, too often marginalized communities are left to the side. They&#8217;re left back,&#8221; Walz said.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40541485/exclusive-can-minnesota-keep-its-cannabis-industry-local-amid-out-of-state-pressure-legal-expert">EXCLUSIVE: Can Minnesota Keep Its Cannabis Industry Local Amid Out-Of-State Pressure? Legal Expert Weighs In</a></li>
</ul>
Cover: Photo by <a href="https://www.pexels.com/es-es/foto/vehiculos-en-la-carretera-cerca-de-edificios-altos-3859774/">Josh Hild</a> via Pexels

Regulations

Politics

Markets

Minnesota's Cannabis License Lottery Faces Legal Delays Over Rejections Dispute

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!



We&rsquo;ve got loads of earnings reports for Q4 this morning and more news worth checking out.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Zeo Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/zeo-stock-quote/">ZEO</a>) stock is rocketing more than 69% after completing a <a href="https://finance.yahoo.com/news/esgen-acquisition-corp-sunergy-renewables-185900477.html">special purpose acquisition company (SPAC) merger</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) shares are soaring over 48% alongside heavy pre-market trading.</li>



<li>Cardlytics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock is surging more than 40% <a href="https://finance.yahoo.com/news/cardlytics-announces-fourth-quarter-full-200300680.html">on strong Q4 earnings</a>.</li>



<li>Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) shares are gaining over 35% after falling hard yesterday <a href="https://investorplace.com/2024/03/why-is-fisker-fsr-stock-down-41-today/">on bankruptcy reports</a>.</li>



<li>Madrigal Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdgl-stock-quote/">MDGL</a>) stock is rising more than 23% on <a href="https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html">approval for its NASH treatment</a>.</li>



<li>RLX Technology (NYSE:<a href="https://investorplace.com/stock-quotes/rlx-stock-quote/">RLX</a>) shares are increasing over 14% alongside its <a href="https://www.fox44news.com/business/press-releases/cision/20240315CN62324/rlx-technology-announces-unaudited-fourth-quarter-and-fiscal-year-2023-financial-results">Q4 earnings report</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) stock is climbing more than 13% as it also released <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-fourth-quarter-full-year-2023-results-2024-03-14">Q4 earnings results</a>.</li>



<li>Better Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bttx-stock-quote/">BTTX</a>) shares are heading over 12% higher after falling yesterday on plans for <a href="https://www.nasdaq.com/press-release/better-therapeutics-announces-it-will-seek-strategic-alternatives-and-will-be">strategic alternatives and delisting</a>.</li>



<li>Akebia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/akba-stock-quote/">AKBA</a>) stock is jumping more than 11% on <a href="https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-business-highlights-302089807.html">steady Q4 earnings</a>.</li>



<li>NeuroSense Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrsn-stock-quote/">NRSN</a>) shares are up over 10% without any clear news this morning.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>LianBio (NASDAQ:<a href="https://investorplace.com/stock-quotes/lian-stock-quote/">LIAN</a>) stock is crashing more than 95% <a href="https://www.nasdaq.com/press-release/lianbio-announces-voluntarily-delisting-from-nasdaq-2024-02-28">alongside its voluntary delisting</a>.</li>



<li>Lucy Scientific Discovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsdi-stock-quote/">LSDI</a>) shares are diving over 29% on Friday morning.</li>



<li>Tracon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is tumbling more than 24% as it continues a recent downward trend.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) shares are taking a 17% beating after rallying yesterday.</li>



<li>Kopin (NASDAQ:<a href="https://investorplace.com/stock-quotes/kopn-stock-quote/">KOPN</a>) stock is sliding over 13% with the release of its <a href="https://www.nasdaq.com/press-release/kopin-corporation-reports-financial-results-for-the-fourth-quarter-and-full-year-2023">latest earnings report</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are decreasing more than 12% <a href="https://investorplace.com/2024/03/why-is-presto-automation-prst-stock-up-77-today/">after jumping yesterday</a>.</li>



<li>Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) stock is dropping over 11% <a href="https://www.cnbc.com/2024/03/14/adobe-adbe-q1-earnings-report-2024.html">on weak guidance</a>.</li>



<li>Pyxis Oncology (NASDAQ:<a href="https://investorplace.com/stock-quotes/pyxs-stock-quote/">PYXS</a>) shares are slipping more than 11% today.</li>



<li>C3is (NASDAQ:<a href="https://investorplace.com/stock-quotes/ciss-stock-quote/">CISS</a>) stock is dipping over 11% on Friday.</li>



<li>Acacia Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/actg-stock-quote/">ACTG</a>) shares close out our pre-market stock movers down more than 11% after releasing its <a href="https://finance.yahoo.com/news/acacia-research-corp-actg-reports-213553539.html">Q4 earnings report</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-march-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

An update from Better Therapeutics, Inc. (BTTX) is now available. Better Therapeutics, Inc. is set to be delisted from the Nasdaq following their v...

Better Therapeutics Overhaul and Nasdaq Delisting

Geron, Graphite Bio, Immuneering among healthcare movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!



We&rsquo;ve got loads of earnings reports for the fourth quarter this morning and more news worth checking out.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Zeo Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/zeo-stock-quote/">ZEO</a>) stock is rocketing more than 69% after completing a <a href="https://finance.yahoo.com/news/esgen-acquisition-corp-sunergy-renewables-185900477.html">special purpose acquisition company (SPAC) merger</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) shares are soaring over 48% alongside heavy pre-market trading.</li>



<li>Cardlytics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock is surging more than 40% <a href="https://finance.yahoo.com/news/cardlytics-announces-fourth-quarter-full-200300680.html">on strong Q4 earnings</a>.</li>



<li>Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) shares are gaining over 35% after falling hard yesterday <a href="https://investorplace.com/2024/03/why-is-fisker-fsr-stock-down-41-today/">on bankruptcy reports</a>.</li>



<li>Madrigal Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdgl-stock-quote/">MDGL</a>) stock is rising more than 23% on <a href="https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html">approval for its NASH treatment</a>.</li>



<li>RLX Technology (NYSE:<a href="https://investorplace.com/stock-quotes/rlx-stock-quote/">RLX</a>) shares are increasing over 14% alongside its <a href="https://www.fox44news.com/business/press-releases/cision/20240315CN62324/rlx-technology-announces-unaudited-fourth-quarter-and-fiscal-year-2023-financial-results">Q4 earnings report</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) stock is climbing more than 13% as it also released <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-fourth-quarter-full-year-2023-results-2024-03-14">Q4 earnings results</a>.</li>



<li>Better Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bttx-stock-quote/">BTTX</a>) shares are heading over 12% higher after falling yesterday on plans for <a href="https://www.nasdaq.com/press-release/better-therapeutics-announces-it-will-seek-strategic-alternatives-and-will-be">strategic alternatives and delisting</a>.</li>



<li>Akebia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/akba-stock-quote/">AKBA</a>) stock is jumping more than 11% on <a href="https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-business-highlights-302089807.html">steady Q4 earnings</a>.</li>



<li>NeuroSense Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrsn-stock-quote/">NRSN</a>) shares are up over 10% without any clear news this morning.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>LianBio (NASDAQ:<a href="https://investorplace.com/stock-quotes/lian-stock-quote/">LIAN</a>) stock is crashing more than 95% <a href="https://www.nasdaq.com/press-release/lianbio-announces-voluntarily-delisting-from-nasdaq-2024-02-28">alongside its voluntary delisting</a>.</li>



<li>Lucy Scientific Discovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsdi-stock-quote/">LSDI</a>) shares are diving over 29% on Friday morning.</li>



<li>Tracon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is tumbling more than 24% as it continues a recent downward trend.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) shares are taking a 17% beating after rallying yesterday.</li>



<li>Kopin (NASDAQ:<a href="https://investorplace.com/stock-quotes/kopn-stock-quote/">KOPN</a>) stock is sliding over 13% with the release of its <a href="https://www.nasdaq.com/press-release/kopin-corporation-reports-financial-results-for-the-fourth-quarter-and-full-year-2023">latest earnings report</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are decreasing more than 12% <a href="https://investorplace.com/2024/03/why-is-presto-automation-prst-stock-up-77-today/">after jumping yesterday</a>.</li>



<li>Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) stock is dropping over 11% <a href="https://www.cnbc.com/2024/03/14/adobe-adbe-q1-earnings-report-2024.html">on weak guidance</a>.</li>



<li>Pyxis Oncology (NASDAQ:<a href="https://investorplace.com/stock-quotes/pyxs-stock-quote/">PYXS</a>) shares are slipping more than 11% today.</li>



<li>C3is (NASDAQ:<a href="https://investorplace.com/stock-quotes/ciss-stock-quote/">CISS</a>) stock is dipping over 11% on Friday.</li>



<li>Acacia Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/actg-stock-quote/">ACTG</a>) shares close out our pre-market stock movers down more than 11% after releasing its <a href="https://finance.yahoo.com/news/acacia-research-corp-actg-reports-213553539.html">Q4 earnings report</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-march-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VERI, STI and VERB among mid-day movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!



We&rsquo;ve got loads of earnings reports for the fourth quarter this morning and more news worth checking out.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Zeo Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/zeo-stock-quote/">ZEO</a>) stock is rocketing more than 69% after completing a <a href="https://finance.yahoo.com/news/esgen-acquisition-corp-sunergy-renewables-185900477.html">special purpose acquisition company (SPAC) merger</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) shares are soaring over 48% alongside heavy pre-market trading.</li>



<li>Cardlytics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock is surging more than 40% <a href="https://finance.yahoo.com/news/cardlytics-announces-fourth-quarter-full-200300680.html">on strong Q4 earnings</a>.</li>



<li>Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) shares are gaining over 35% after falling hard yesterday <a href="https://investorplace.com/2024/03/why-is-fisker-fsr-stock-down-41-today/">on bankruptcy reports</a>.</li>



<li>Madrigal Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdgl-stock-quote/">MDGL</a>) stock is rising more than 23% on <a href="https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html">approval for its NASH treatment</a>.</li>



<li>RLX Technology (NYSE:<a href="https://investorplace.com/stock-quotes/rlx-stock-quote/">RLX</a>) shares are increasing over 14% alongside its <a href="https://www.fox44news.com/business/press-releases/cision/20240315CN62324/rlx-technology-announces-unaudited-fourth-quarter-and-fiscal-year-2023-financial-results">Q4 earnings report</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) stock is climbing more than 13% as it also released <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-fourth-quarter-full-year-2023-results-2024-03-14">Q4 earnings results</a>.</li>



<li>Better Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bttx-stock-quote/">BTTX</a>) shares are heading over 12% higher after falling yesterday on plans for <a href="https://www.nasdaq.com/press-release/better-therapeutics-announces-it-will-seek-strategic-alternatives-and-will-be">strategic alternatives and delisting</a>.</li>



<li>Akebia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/akba-stock-quote/">AKBA</a>) stock is jumping more than 11% on <a href="https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-business-highlights-302089807.html">steady Q4 earnings</a>.</li>



<li>NeuroSense Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrsn-stock-quote/">NRSN</a>) shares are up over 10% without any clear news this morning.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>LianBio (NASDAQ:<a href="https://investorplace.com/stock-quotes/lian-stock-quote/">LIAN</a>) stock is crashing more than 95% <a href="https://www.nasdaq.com/press-release/lianbio-announces-voluntarily-delisting-from-nasdaq-2024-02-28">alongside its voluntary delisting</a>.</li>



<li>Lucy Scientific Discovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsdi-stock-quote/">LSDI</a>) shares are diving over 29% on Friday morning.</li>



<li>Tracon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is tumbling more than 24% as it continues a recent downward trend.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) shares are taking a 17% beating after rallying yesterday.</li>



<li>Kopin (NASDAQ:<a href="https://investorplace.com/stock-quotes/kopn-stock-quote/">KOPN</a>) stock is sliding over 13% with the release of its <a href="https://www.nasdaq.com/press-release/kopin-corporation-reports-financial-results-for-the-fourth-quarter-and-full-year-2023">latest earnings report</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are decreasing more than 12% <a href="https://investorplace.com/2024/03/why-is-presto-automation-prst-stock-up-77-today/">after jumping yesterday</a>.</li>



<li>Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) stock is dropping over 11% <a href="https://www.cnbc.com/2024/03/14/adobe-adbe-q1-earnings-report-2024.html">on weak guidance</a>.</li>



<li>Pyxis Oncology (NASDAQ:<a href="https://investorplace.com/stock-quotes/pyxs-stock-quote/">PYXS</a>) shares are slipping more than 11% today.</li>



<li>C3is (NASDAQ:<a href="https://investorplace.com/stock-quotes/ciss-stock-quote/">CISS</a>) stock is dipping over 11% on Friday.</li>



<li>Acacia Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/actg-stock-quote/">ACTG</a>) shares close out our pre-market stock movers down more than 11% after releasing its <a href="https://finance.yahoo.com/news/acacia-research-corp-actg-reports-213553539.html">Q4 earnings report</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-march-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ACTG

ADBE

AKBA

AMPS

BFRI

BTTX

CDLX

CISS

GERN

GOEV

GRPH

GRPN

HCMA

HOUS

IMRX

JTAI

KOPN

LIAN

LSDI

MDAI

MDGL

NRSN

PRST

PYXS

TCON

VERB

VERI

Screenshot 2024-02-22 at 11.51.01 PM

Biotech

General

Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease

Diabetes Is The Most Expensive Chronic Condition In America With Healthcare Costs Continuing To Rise, Making Addressing Its Root Causes Even More Important

Press Releases

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

BTCY

Lake Street

Chardan Capital

Comments

Better Therapeutics

Notizie

Ultime notizie per Better Therapeutics (OTC:BTTX) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO